Why are the hoppin’-mad Teabaggers so oddly quiet these days, ever since the BP oil disaster? That’s what Thomas Frank, author of What’s The Matter With Kansas? asked last week in his column, “Laissez-faire Meets The Oil Spill.” Ideologically, it’s painfully obvious why the Teabaggers are now the Teagaggers: their free-market gospel got mugged by oil-drenched reality — a reality so horrific that even pollster Frank Luntz couldn’t spin the BP disaster as the government’s fault. Best to just shut up when you’re that wrong.
But there’s another, more concrete reason why the Tea Party revolutionaries melted back into their suburbs as soon as the enormity of the Gulf spill disaster hit: The Tea Party evolved out of the pro-offshore drilling astroturf movement in 2008. They even share some of the same organizers and front groups, from PR operative like Eric Odom, to advocacy groups like FreedomWorks, whose combined efforts on the “Drill Here! Drill now!” astroturf campaign succeeded in opening up all of America’s coastlines and waters to offshore drilling, overturning a 27-year ban thanks to threats of “a Boston-style Tea Party,” as one Republican put it in the summer of 2008.
We have been following this movement from the beginning. Back in February 2009, on the eve of the first Tea Party protest, we published the first investigative article exposing the hidden relationship between the fake-”spontaneous” Tea Party protests that month, and the Republican machine that backed and promoted the campaign. Our research led again and again to the right-wing Koch brothers, who are worth a combined $32 billion as owners of the largest private oil company in America, Koch Industries. Koch-linked front groups like FreedomWorks and the Sam Adams Alliance (named after the leader of the original Boston Tea Party) played key roles in both the 2008 campaign to deregulate offshore drilling, and in the Tea Party movement.
Eric Odom, the PR flak who launched the Tea Party in February 2009, is the same Eric Odom who in August 2008 organized Republican Twitter-mobs who crashed Capitol Hill chanting “Drill here! Drill now!” to force Congress to open up…
A reader brought to my attention a new rumor going around about the strange behavior of Goldman Sachs’s stock price. On April 27, the day Blankfein was dragged before Congress to testify about fraud, Goldman’s stock rose–even though every other financial stock in the S&P 500 dropped, all 78 of them, on a day when the overall S&P average tanked 2.3 percent.
Goldman Sachs Group Inc. had the only gain among 79 financial companies in the Standard & Poor’s 500 Indexas executives testified to a Senate subcommittee about mortgage securities.
Goldman Sachs advanced 0.7 percent to $153.04, while theS&P 500 Financials Index retreated 3.4 percent.
It’s an obvious question, just wondering if anyone has looked into this because as one reader wrote, “it makes no sense whatsoever.” Except as an expensive PR exercise funded by the bank’s insiders.
Whatever the case, that unexpected stock jump turned out to be wonderful news, the billionaires’ smackdown on all the resentful parasites trying to take down Goldman Sachs–this according to all sorts of media lickspittles who are rooting for Goldman. Here for example is The New York Daily Newsgloating over Goldman’s unexpected stock price rise:
I would be happy to let the whole United States Senate curse at me for just a fraction of the $2.8 million Goldman Sachs CEO Lloyd Blankfein made while he was testifying before a subcommittee this week.
The opinions of the senators carry so little weight that
In early July, Steven gave a presentation at the Value Investing Seminar in southern Italy, where he talked about the current investing climate which is stranger than fiction. Given today’s investment environment looks like a wonderland which only Lewis Carroll could have imagined prior to the most recent decade, the title of the presentation was Through the Quantum Glass, in deference to his great work Through the Looking Glass.
The surprise vote in favor of the U.K. leaving the European Union on June 23 unleashed shockwaves across the global economy, wiping trillions off the value of global assets. The referendum reshaped the British political landscape, and genera...
Reminder: OpTrader is available to chat with Members, comments are found below each post.
This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).
We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options.
Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.
To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here
"When you let the free market take over, the little people get screwed and bankers get rich. Chile tried privatizing retirement plans and surprise, surprise, fund manager ate the profits… Pretty sure the results would be the same here..." ~ Jean-Luc
I was so pleased yesterday by the announcement that I have joined the Research team at GoldCore as it meant that I could finally start talking about it and was back in a role that lets me indulge in my passion by researching and geeking out on all things gold, silver and money.
Reminder: Pharmboy is available to chat with Members, comments are found below each post.
Epizyme was founded in 2007, and trying to create drugs to treat patient's cancer by focusing on genetically-linked differences between normal and cancer cells. Cancer areas of focus include leukemia, Non-Hodgkin's lymphoma and breast cancer. One of the Epizme cofounders, H. Robert Horvitz, won the Nobel Prize in Medicine in 2002 for "discoveries concerning genetic regulation of organ development and programmed cell death."
Before discussing the drug targets of Epizyme, understanding epigenetics is crucial to comprehend the company's goals.
Genetic components are the DNA sequences that are 'inherited.' Some of these genes are stronger than others in their expression (e.g., eye color). Yet, some genes turn on or off due to external factors (environmental), and it is und...
Note: The material presented in this commentary is provided for
informational purposes only and is based upon information that is
considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW)
nor its affiliates
warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
Site owned and operated by PSW Investments, LLC. Contact us at: 403 Central Avenue, Hawthorne, NJ 07506. Phone: (201) 743-8009. Email: firstname.lastname@example.org.